Salipro Biotech AB
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Salipro Biotech AB is a biotechnology company that provides a proprietary platform technology for the stabilization of membrane proteins to enable drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Salipro Biotech AB Comparables
Compare Salipro Biotech AB with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eurofins CALIXAR | 83% | |
| Cube Biotech | 81% | |
| Peptidisc Biotech | 81% | |
Salipro Biotech AB Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 45% MoM.
- Jan 25, 2026
Monthly visitors grew 356% MoM.
Salipro Biotech AB Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Salipro Biotech AB's valuation, stock price, and market status.